nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Hyperaemia—Carmustine—malignant glioma	0.124	0.149	CcSEcCtD
Latanoprost—Embolism—Temozolomide—malignant glioma	0.0562	0.0679	CcSEcCtD
Latanoprost—Dry eye—Temozolomide—malignant glioma	0.0333	0.0402	CcSEcCtD
Latanoprost—Eye pain—Carmustine—malignant glioma	0.03	0.0362	CcSEcCtD
Latanoprost—Eye pain—Temozolomide—malignant glioma	0.029	0.035	CcSEcCtD
Latanoprost—Diplopia—Carmustine—malignant glioma	0.0271	0.0327	CcSEcCtD
Latanoprost—Diplopia—Temozolomide—malignant glioma	0.0262	0.0316	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0236	0.0285	CcSEcCtD
Latanoprost—Bronchitis—Temozolomide—malignant glioma	0.0218	0.0263	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0211	0.0254	CcSEcCtD
Latanoprost—Tafluprost—PTGS2—malignant glioma	0.0204	1	CrCbGaD
Latanoprost—Urinary tract infection—Carmustine—malignant glioma	0.0203	0.0245	CcSEcCtD
Latanoprost—Urinary tract infection—Temozolomide—malignant glioma	0.0196	0.0237	CcSEcCtD
Latanoprost—Connective tissue disorder—Carmustine—malignant glioma	0.0184	0.0222	CcSEcCtD
Latanoprost—Connective tissue disorder—Temozolomide—malignant glioma	0.0178	0.0215	CcSEcCtD
Latanoprost—Mediastinal disorder—Temozolomide—malignant glioma	0.0163	0.0197	CcSEcCtD
Latanoprost—Erythema—Carmustine—malignant glioma	0.0163	0.0197	CcSEcCtD
Latanoprost—Back pain—Carmustine—malignant glioma	0.0158	0.0191	CcSEcCtD
Latanoprost—Erythema—Temozolomide—malignant glioma	0.0158	0.019	CcSEcCtD
Latanoprost—Vision blurred—Carmustine—malignant glioma	0.0154	0.0186	CcSEcCtD
Latanoprost—Back pain—Temozolomide—malignant glioma	0.0153	0.0184	CcSEcCtD
Latanoprost—Vision blurred—Temozolomide—malignant glioma	0.0149	0.0179	CcSEcCtD
Latanoprost—Chest pain—Carmustine—malignant glioma	0.0139	0.0168	CcSEcCtD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—APOD—malignant glioma	0.0136	0.0904	CbGpPWpGaD
Latanoprost—Arthralgia—Temozolomide—malignant glioma	0.0134	0.0162	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0133	0.0161	CcSEcCtD
Latanoprost—Oedema—Carmustine—malignant glioma	0.0133	0.0161	CcSEcCtD
Latanoprost—Discomfort—Temozolomide—malignant glioma	0.0133	0.016	CcSEcCtD
Latanoprost—Oedema—Temozolomide—malignant glioma	0.0129	0.0155	CcSEcCtD
Latanoprost—Nervous system disorder—Temozolomide—malignant glioma	0.0126	0.0152	CcSEcCtD
Latanoprost—Skin disorder—Temozolomide—malignant glioma	0.0125	0.0151	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0121	0.0147	CcSEcCtD
Latanoprost—Dyspnoea—Carmustine—malignant glioma	0.0119	0.0143	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0117	0.0142	CcSEcCtD
Latanoprost—Dyspnoea—Temozolomide—malignant glioma	0.0115	0.0139	CcSEcCtD
Latanoprost—Pain—Carmustine—malignant glioma	0.0114	0.0138	CcSEcCtD
Latanoprost—Pain—Temozolomide—malignant glioma	0.011	0.0133	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—malignant glioma	0.0101	0.067	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.00957	0.0634	CbGpPWpGaD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—malignant glioma	0.0095	0.063	CbGpPWpGaD
Latanoprost—Pruritus—Temozolomide—malignant glioma	0.00911	0.011	CcSEcCtD
Latanoprost—Dizziness—Carmustine—malignant glioma	0.00881	0.0106	CcSEcCtD
Latanoprost—Dizziness—Temozolomide—malignant glioma	0.00852	0.0103	CcSEcCtD
Latanoprost—Rash—Carmustine—malignant glioma	0.0084	0.0101	CcSEcCtD
Latanoprost—Dermatitis—Carmustine—malignant glioma	0.0084	0.0101	CcSEcCtD
Latanoprost—Headache—Carmustine—malignant glioma	0.00835	0.0101	CcSEcCtD
Latanoprost—Rash—Temozolomide—malignant glioma	0.00812	0.0098	CcSEcCtD
Latanoprost—Dermatitis—Temozolomide—malignant glioma	0.00811	0.00979	CcSEcCtD
Latanoprost—Headache—Temozolomide—malignant glioma	0.00807	0.00974	CcSEcCtD
Latanoprost—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.00476	0.0315	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—CXCR3—malignant glioma	0.00386	0.0256	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.00367	0.0243	CbGpPWpGaD
Latanoprost—SLC22A1—Amine compound SLC transporters—SLC6A3—malignant glioma	0.0033	0.0219	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00292	0.0194	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00226	0.015	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00198	0.0132	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00193	0.0128	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00191	0.0127	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—KNG1—malignant glioma	0.00181	0.012	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00178	0.0118	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00175	0.0116	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00168	0.0111	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00161	0.0107	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00153	0.0102	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00153	0.0101	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOD—malignant glioma	0.00149	0.00986	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCR4—malignant glioma	0.00147	0.00977	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00144	0.00953	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00143	0.00949	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00137	0.00912	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00131	0.00872	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00131	0.00869	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00131	0.00868	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00129	0.00856	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LATS2—malignant glioma	0.00126	0.00834	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.0012	0.00793	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—F2—malignant glioma	0.00117	0.00774	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCR3—malignant glioma	0.00109	0.00726	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00104	0.00692	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—BDKRB2—malignant glioma	0.001	0.00664	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000981	0.00651	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LATS1—malignant glioma	0.000953	0.00632	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—KNG1—malignant glioma	0.000911	0.00604	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000856	0.00568	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR4—malignant glioma	0.000832	0.00552	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000784	0.0052	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000783	0.00519	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000773	0.00513	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000769	0.0051	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000761	0.00505	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR4—malignant glioma	0.000756	0.00501	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000723	0.0048	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000699	0.00463	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RTEL1—malignant glioma	0.000698	0.00463	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000685	0.00454	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000666	0.00442	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000665	0.00441	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDK—malignant glioma	0.000644	0.00427	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCR3—malignant glioma	0.000618	0.0041	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000616	0.00409	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—DTX1—malignant glioma	0.000614	0.00408	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BCHE—malignant glioma	0.000589	0.00391	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—F2—malignant glioma	0.000589	0.0039	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000586	0.00389	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—BDKRB2—malignant glioma	0.000566	0.00375	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCR3—malignant glioma	0.000562	0.00373	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—SLC6A3—malignant glioma	0.000554	0.00368	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000545	0.00361	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000538	0.00357	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000522	0.00346	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—KNG1—malignant glioma	0.000515	0.00341	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—BDKRB2—malignant glioma	0.000514	0.00341	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000508	0.00337	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SUFU—malignant glioma	0.000488	0.00324	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HEY2—malignant glioma	0.000482	0.0032	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GFAP—malignant glioma	0.000471	0.00312	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KNG1—malignant glioma	0.000467	0.0031	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000467	0.00309	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPHK1—malignant glioma	0.000456	0.00302	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HEY1—malignant glioma	0.000446	0.00296	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR4—malignant glioma	0.000446	0.00296	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H3B—malignant glioma	0.000434	0.00288	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—malignant glioma	0.000415	0.00275	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MMP3—malignant glioma	0.000414	0.00275	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COX8A—malignant glioma	0.000401	0.00266	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAG2—malignant glioma	0.000396	0.00263	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000393	0.0026	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ASMT—malignant glioma	0.000341	0.00226	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000341	0.00226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—H3F3A—malignant glioma	0.000335	0.00222	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—F2—malignant glioma	0.000333	0.00221	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCR3—malignant glioma	0.000332	0.0022	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000329	0.00218	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000328	0.00217	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NTRK2—malignant glioma	0.000323	0.00214	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—YWHAE—malignant glioma	0.000323	0.00214	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FLT1—malignant glioma	0.000321	0.00213	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BCAN—malignant glioma	0.000321	0.00213	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—DUSP6—malignant glioma	0.00032	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—malignant glioma	0.000318	0.00211	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAG1—malignant glioma	0.000316	0.00209	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH3—malignant glioma	0.000315	0.00209	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000313	0.00208	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FBXW7—malignant glioma	0.000309	0.00205	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BDKRB2—malignant glioma	0.000303	0.00201	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—F2—malignant glioma	0.000302	0.002	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000301	0.002	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BRAF—malignant glioma	0.000301	0.002	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000298	0.00198	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT2—malignant glioma	0.000291	0.00193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—malignant glioma	0.000289	0.00192	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PTPN11—malignant glioma	0.000284	0.00188	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH2—malignant glioma	0.000282	0.00187	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—malignant glioma	0.00028	0.00186	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KNG1—malignant glioma	0.000276	0.00183	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT2—malignant glioma	0.000264	0.00175	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NTRK1—malignant glioma	0.000263	0.00175	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH2—malignant glioma	0.000258	0.00171	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—malignant glioma	0.000254	0.00169	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MDM2—malignant glioma	0.000252	0.00167	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—RAF1—malignant glioma	0.000251	0.00167	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP3—malignant glioma	0.000245	0.00162	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—malignant glioma	0.000244	0.00162	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2B6—malignant glioma	0.000243	0.00161	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN2B—malignant glioma	0.000242	0.00161	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTK2—malignant glioma	0.000235	0.00156	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—malignant glioma	0.000234	0.00155	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HES1—malignant glioma	0.000231	0.00153	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCOR1—malignant glioma	0.00023	0.00153	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RAF1—malignant glioma	0.000227	0.0015	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—malignant glioma	0.000224	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH1—malignant glioma	0.000222	0.00147	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—malignant glioma	0.000221	0.00147	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFRA—malignant glioma	0.00022	0.00146	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SPHK1—malignant glioma	0.000215	0.00143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPP1—malignant glioma	0.000214	0.00142	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—malignant glioma	0.000213	0.00141	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2C18—malignant glioma	0.000211	0.0014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—malignant glioma	0.000203	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—malignant glioma	0.000203	0.00134	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFB—malignant glioma	0.000198	0.00131	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR1—malignant glioma	0.000197	0.00131	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—malignant glioma	0.000194	0.00129	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—malignant glioma	0.000187	0.00124	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—malignant glioma	0.000185	0.00123	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—F2—malignant glioma	0.000178	0.00118	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FN1—malignant glioma	0.000178	0.00118	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BAD—malignant glioma	0.000176	0.00117	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH1—malignant glioma	0.000175	0.00116	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD80—malignant glioma	0.000171	0.00113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—malignant glioma	0.000171	0.00113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—malignant glioma	0.000171	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—malignant glioma	0.00017	0.00113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGF—malignant glioma	0.000169	0.00112	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTPN11—malignant glioma	0.000168	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BRAF—malignant glioma	0.00016	0.00106	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS1—malignant glioma	0.00016	0.00106	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT2—malignant glioma	0.000156	0.00104	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—malignant glioma	0.000156	0.00103	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—malignant glioma	0.00015	0.000996	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000149	0.000986	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BCHE—malignant glioma	0.000148	0.000985	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—malignant glioma	0.000147	0.000975	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC5A5—malignant glioma	0.000147	0.000973	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF2—malignant glioma	0.000144	0.000953	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000135	0.000896	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—malignant glioma	0.000135	0.000896	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDM2—malignant glioma	0.000134	0.000892	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAF1—malignant glioma	0.000134	0.000889	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—malignant glioma	0.000133	0.000879	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—malignant glioma	0.000131	0.000868	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—malignant glioma	0.000126	0.000834	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—malignant glioma	0.000121	0.000806	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—malignant glioma	0.00012	0.000798	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—malignant glioma	0.00012	0.000797	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—malignant glioma	0.000118	0.000783	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAT—malignant glioma	0.000115	0.000762	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—malignant glioma	0.000114	0.000754	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTEN—malignant glioma	0.000113	0.00075	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—malignant glioma	0.00011	0.000732	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOR1—malignant glioma	0.000109	0.00072	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—malignant glioma	0.000102	0.000677	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—malignant glioma	0.000101	0.000671	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—malignant glioma	9.4e-05	0.000623	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—malignant glioma	9.19e-05	0.00061	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—malignant glioma	8.85e-05	0.000587	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—malignant glioma	8.68e-05	0.000576	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—malignant glioma	8.06e-05	0.000535	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—malignant glioma	7.98e-05	0.000529	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—malignant glioma	7.78e-05	0.000516	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—malignant glioma	7.72e-05	0.000512	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—malignant glioma	7.08e-05	0.00047	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—malignant glioma	6.52e-05	0.000432	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—malignant glioma	6.18e-05	0.00041	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—malignant glioma	6.12e-05	0.000406	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTEN—malignant glioma	5.34e-05	0.000354	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—malignant glioma	3.76e-05	0.00025	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—malignant glioma	3.08e-05	0.000204	CbGpPWpGaD
